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 INTRAVASCULAR VOLUME STATUS IN 1ST EPISODE OF 
NEPHROTIC SYNDROME-A SINGLE CENTER STUDY 
 
ABSTRACT 
Aim and Objectives: To assess the intravascular volume status in children 
presenting with first episode of Nephrotic Syndrome in our centre, ICH&HC, 
Madras Medical College Chennai. 
Methodology-A prospective observational study was done on all children 
presenting with 1st episode of nephrotic syndrome based on inclusion and 
exclusion criteria in the general pediatric wards in ICH. 42 children who satisfied 
the inclusion and exclusion criteria between January-September 2015 were 
enrolled into the study. Detailed history and clinical examination were done for 
these patients. Tests for FeNa, Fractional urinary excretion of potassium, Echo to 
look for IVC collapsibility index was done for all of these patients on admission. 
Results were entered in an excel sheet and data was analyzed using open epi 
version 2.3.1 for statistics. 
Results-This study included 42 participant 16(38.1%) were females and 26(61.9%) 
were males. 20(47.6%) patients were found to have a FeNa of < 1,whereas 
22(52.4%) patients were found to have a value of FeNa >1. 16(38.1%)  patients 
were found to have a fractional urinary excretion of potassium of > 60 %,whereas  
26 (61.9%) patients in this study had a fractional urinary excretion of potassium of 
<60 %.A total of 16(38.1% ) patients were found to a have an IVCCI < 50 %. 
26(61.9 %) patients were found to have an IVCCI > 50 %. From the above values, 
hypovolemia was defined as having FENa<1 and Uk/Uk+Una>60% and IVC 
collapsibility > 50 %. In this study 16 (38.1%) patients had hypovolemia satisfying 
the above criteria.  22(52.4%) patients had FeNa >1 and fractional urinary 
potassium excretion <60 % and IVCCI < 50 %.  Hence these patients were 
classified as hypervolemic.  4(9.5%) patients had a FeNa <1 but fractional urinary 
potassium excretion <60 % and IVCCI < 50 %. Since these patients did not satisfy 
the criteria for hypovolemia fully, there were classified as having hypervolemic or 
normovolemic intravascular volume status.  Hence a total of 16(38.1%) patients 
were classified as having hypovolemia whereas the rest of the 26(61.9 %) were 
classified as having hypervolemia or normovolemia(not having hypovolemia). 
Conclusion- Intravascular volume status was found to be decreased/hypovolemic 
in 38% of the patients in this study whereas 62 % of the patients had hypervolemic 
or normovolemic intravascular status. Since a significant number of patients were 
found to be hypovolemic, intravascular volume status must be assessed in patients 
with 1st episode of nephrotic syndrome before the institution of diuretic therapy for 
treating edema.  
Key words- 1st episode nephrotic syndrome, intravascular volume status, FeNa, 
Fractional urinary excretion of potassium, IVC collapsibility index. 
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Nephrotic syndrome is one of the commonest diseases involving the 
glomerulus in Childhood . This disease is caused by factors which 
increase the permeability of the glomerular filtration barrier1. 
  
Nephrotic syndrome is characterized by 4 main features1- 
-massive proteinuria 
-hypoalbuminia 
-hyperlipedemia 
-with or without edema 
 
CLASSIFICATION 
 
ON THE BASIS OF AGE OF PRESENTATION1 
 
Classification based upon the age of presentation is needed because of the  
variations in the underlying histology and management in the  
different groups  
-<3 months of age-congenital nephrotic syndrome 
-3m to1 yr-infantile nephrotic syndrome 
->1 yr-childhood nephrotic  syndrome 
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ON THE BASIS OF RESPONSIVENESS TO TREATMENT 
 
-Steroid sensitive nephrotic syndrome- 
 Responsive to normal regimen of  steroid with decrease in 
proteinuria and symptoms 
-Steroid dependent nephrotic syndrome- 
 Two consecutive relapse during alternate day steroid regimen (or) 
Within 14 days of stopping steroids. 
-Steroid resistant nephrotic syndrome- 
 Inability to induce remission in 8 weeks of full dose steroids. 
 
ON THE BASIS OF HISTOLOGY 
 
-Minimal change nephrotic syndrome- 
Most common type of nephrotic syndrome in children. Accounts 
 for about 90% of all the cases of all the nephrotic syndrome in   
childhood.   
Light microscopy-normal 
Immunoflurosence-negative 
Electron microscopy-fusion of foot process 
Response to steroids-90% 
 
-Focal segmental glomerulosclerosis 
 Less common subtype. 
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May present with haematuria, hypertension, acute renal failure in addition 
to features of nephrotic syndrome. 
 Light microscopy-focal sclerotic lesions 
Immunoflurosence-IgM, C3 in lesions 
Electron microscopy-fusion of foot processes 
Response to steroids-15-20% 
 
-Membranous nephropathy 
Less common subtype. 
May present with haematuria,hypertension,acute renal failure in addition 
to features of nephrotic syndrome. 
Associated with renal vein thrombosis,malignancy,SLE, Hepatitis B. 
 Light microscopy-Thickened GBM,spikes 
Immunoflurosence-fine granular IgG ,C3  
Electron microscopy-subepithelial deposits 
Response to steroids-may be slow progression 
 
-Membranoproliferative glomerulonephritis type 1 
Less common subtype. 
May present with haematuria,hypertension,acute renal failure in addition 
to features of nephrotic syndrome. 
 Light microscopy-Thikened GBM,proliferation 
Immunoflurosence-Granular IgG,C3 
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Electron microscopy-mesangial and subendothelial deposits 
Response to steroids-not yet established 
 
-Membranoproliferative glomerulonephritis type 2 
Less common subtype. 
May present with haematuria,hypertension,acute renal failure in addition 
to features of nephrotic syndrome. 
Associated with partial lipodystrophy. 
 Light microscopy-lobulation 
Immunoflurosence-c3only 
Electron microscopy-dense deposits 
Response to steroids-not yet established 
 
DEFINITION  
 
NEPHROTIC SYNDROME2 
+Proteinuria of more than 
 40 mg/m2/hr or 
 50 mg/kg/day or  
 Urine spot PCR >2 or urine dipstick> 2+ for 3 consecutive days. 
+hypoalbuminia 
 As defined as serum albmin<2.5 gm/dl 
+Hypercholestremia- 
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 As defined by serum cholesterol>200 
With or without edema. 
 
REMISSION 
 Urine protein less than 0.4 mg/m2/hr  or Spot PCR <0.2 or urinary 
dipstick trace or nil for 3 consecutive days. 
 
RELAPSE 
Urine protein more than 40 mg/m2/hr  or Spot PCR >2.0 or  
urinary dipstick 3+ or more for 3 consecutive days 
 
FREQUENT RELAPSE 
 2 or more relapses within 6 months of initial remission (or) 
3 relapses in any 12 month period. 
 
STEROID DEPENDENCE2 
 2consecutive relapses during alternate day steroid regimen or 
within 14days of stopping steroids. 
 
STEROID RESISTANCE2 
 Inability to induce reimission to steroids within 8 weeks of full 
dose of steroids. 
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EPIDEMIOLOGY 
 
Most common age group of presentation of nephrotic syndrome is 3- 6 
yrs1,7.Around 2/3rds present before 6 yrs of age.The ratio among boys to 
girls is 2:1.But by late adoloscence both sexes are equally affected. 
About 90% of the patients are in the most common form known as 
Idiopathic Nephrotic syndrome.Rest of the  10 % may be divided into 
multiple forms. 
Incidence is about 2-3 cases per 100000 children  in developed 
countries with higher incidence in developing countries. 
 
 
 
ETIOLOGY 
 
2IDIOPATHIC NEPHROTIC SYNDROME 
 
Minimal change disease 
 
Focal segmental glomerulosclerosis 
 
Membranous nephropathy 
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Glomerulonephritis associated with nephrotic syndrome–
membranoproliferative glomerulonephritis, crescentic 
glomerulonephritis, immunoglobulin A nephropathy. 
 
GENETIC DISORDERS ASSOCIATED WITH PROTEINURIA OR 
NEPHROTIC SYNDROME 
 
Nephrotic Syndrome (Typical) 
 
Finnish-type congenital nephrotic syndrome (absence of nephrin) 
 
Focal segmental glomerulosclerosis (mutations in nephrin, podocin, 
MYO1E, α-actinin 4, TRPC6) 
 
Diffuse mesangial sclerosis (mutations in laminin β2 chain) 
 
Denys-Drash syndrome (mutations in WT1 transcription factor) 
 
Congenital nephrotic syndrome with lung and skin involvement 
(integrin α-3 mutation) 
 
Mitochondrial disorders 
 
Proteinuria With or Without Nephrotic Syndrome 
 
Nail-patella syndrome (mutation in LMX1B transcription factor) 
 
Alport syndrome (mutation in collagen biosynthesis genes) 
 
Multisystem Syndromes With or Without Nephrotic Syndrome 
 
Galloway-Mowat syndrome 
 
Charcot-Marie-Tooth disease 
 
Jeune syndrome 
 
Cockayne syndrome 
 
Laurence-Moon-Biedl-Bardet syndrome 
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Metabolic Disorders With or Without Nephrotic Syndrome 
 
Alagille syndrome 
 
α1-Antitrypsin deficiency 
 
Fabry disease 
 
Glutaric acidemia 
 
Glycogen storage disease 
 
Hurler syndrome 
 
Partial lipodystrophy 
 
Mitochondrial cytopathies 
 
Sickle cell disease 
 
 
 
 
 
 
 
 
SECONDARY CAUSES OF NEPHROTIC SYNDROME 
 
+Infections like 
 
Endocarditis 
Hepatitis B, C 
HIV-1 
Infectious mononucleosis 
Malaria 
Syphilis (congenital and secondary) 
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Toxoplasmosis 
Schistosomiasis 
Filariasis 
 
+Drugs 
 
Captopril 
Penicillamine 
Gold 
Nonsteroidal antiinflammatory drugs 
Pamidronate 
Interferon 
Mercury 
Heroin 
Lithium 
 
+Others 
 
Immunologic or Allergic Disorders 
 
Vasculitis syndromes 
 
Castleman disease 
 
Kimura disease 
 
Bee sting 
 
Food allergens 
 
Serum sickness 
 19 
 
 
+Associated With Malignant Disease 
 
Lymphoma 
 
Leukemia 
 
Solid tumors 
 
 
 
+Glomerular Hyperfiltration 
 
Oligomeganephronia 
 
Morbid obesity 
 
Adaptation to nephron reduction 
 
 
 
PATHOGENESIS 
 
` Glomerular capillaries are lined by fenestrated endothelium which 
in turn rests on glomerular basement membrane which in turn is covered 
by glomerular epithelium also known as podocytes3.  Neighboring 
podocyte foot processes are covered by cellular extensions called foot 
processes .These structures form the glomerular filtration barrier. 
 
 Nephrotic syndrome can occur as a result of  either structural or 
functional loss of the glomerular filtration membrane.Patients with 
Idiopathic Nephrotic syndrome6 show a break down in the charge 
selective barrier to filtration resulting in massive proteinuria, whereas in  
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genetically determined SRNS, it is the structural alterations in the 
podocytes due to gene mutations which pay a mojor role in pathogenesis 
of the disease. 
 
 The exact cause of breakdown of the filtration barrier in idiopathic 
NS is still not known although there are certain hypotheisis regarding it 
like 
+dysregulation of T cell function 
 
   Provoked by infection,allergen,vaccine, lymphoma etc. 
    
Proteinuria resolving after treatment with immunosuppressive therapy 
supports this theory. 
 
+damage to glomeular filtration barrier due to some soluble factors 
 
   As evidenced by relapse in some patients with FSGS after transplant. 
 
 
PATHOPHYSIOLOGY1.2,3 
 
HYPOALBUNIMIA 
 
Due to the massive urinary protein loss and due to catabolism of proteins 
in renal tubules 
 
 
 
 21 
 
HYPERTRIGLYCERIDEMIA AND HYPERCHOLESTREMIA  
 
This occurs due to the stimulation of the hepatic protein synthesis due to  
 
hypoalbuinimia which includes increased production of  lipoproteins. 
 
THROMBOSIS 
 
This occurs due to the increased hepatic synthesis of  proteins as a result 
of hypoalbminimia. Increased levels of  fators 1,5,7,8,10 and 13 occurs . 
There is also a decrease in levels of antithrombin 3,protein C and S as a 
result of renal protein losses.The increases hematocrit as a result of severe 
volume contraction also results in a hypercoagulable state. 
 
INFECTIONS 
 
Increased risk of  infections in Nephrotic syndrome are as a result of 
decreased levels of serum IgG due to urinary loss as well as due to 
increased levels of serum cholesterol. 
 
Use of immunosuppressive drugs further increase the chances of 
infection. 
 
RENAL FAILURE 
 
Renal failure occurs rarely in Idiopathic NS.When it occurs, it is due to 
acute tubular necrosis due to severe volume contraction or due to bilateral 
renal vein thrombosis. 
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Chronic renal failure is a part of disease process in SRNS due to 
persistently occurring proteinuria over a long period of time.  
 
EDEMA 
 
Decreased oncotic pressure due to decreased plasma albumin leads 
to movement of fluid from the vascular system to the interstitial space. 
Hypoalbuminia and decreased oncotic pressure also trigger sodium 
retention via rennin-angiotensin-aldosterone axis(underfill theory)11 and 
via the increased activation of  ENaC channels in the collecting 
tubules(overfill theory). 
 In a subset of patients due to underfill, there have been 
reported states of  hypovolemia inspite of peripheral edema.These 
patients due to there decreased intravascular volume are at an increased 
risk for developing  thrombotic complications like renal vein 
thrombosis,deep venous thrombosis,pulmonary and cerebral vein 
thrombosis, IVC thrombosis and acute tubular necrosis due to volume 
depletion. 
In another subsetof patients,due to incrased activation of  ENaC 
channels in collecting tubules there is sodium retention which causes 
water retention along with it which is the cause for edema. 
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PATHOLOGY 
 
Normal glomerular filtration membrane 
 
 
 
 
MINIMAL CHANGE GLOMERULAR DISEASE 2,18 
 
Light microscopy-normal or mild increase in mesangial cellularity and 
matrix. 
Immunofuurosence-negative for immune deposits. 
 
 24 
 
Electron microscopy-fusion of foot process 
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Immunofluorescence preparation demonstrating numerous 
lipid droplets in the proximal tubular epithelial cells. 
 
 
DIFUSE MESANGIAL PROLIFERATION 
 
Light microscopy-diffuse increase in mesangial cellularity and matrix. 
Immunofuurosence-trace to 1+ of  IgM or IgA or C3 deposits in the 
mesangium. 
Electron microscopy-fusion of foot processs along with diffuse 
proliferation of mesangial cells and matrix.  
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Diffuse mesangial proliferation 
 
 
FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS 
 
Light microscopy-focal(some but not all glomeruli involved ) and 
segmental(part of glomerular tuft involved) sclerosis and mesangial 
proliferation. 
Immunofuurosence-IgM and C3 deposits in areas of sclerosis. 
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Electron microscopy-obliteration of capillary lumen in tuft having 
segmental sclerosis while the non involved segment has fusion of foot 
processes. 
There are 5 histological variants of FSGS 
-FSGS not otherwise specified. 
-collapsing variant:found in patients with HIV,parvo virus infection;worst  
prognosis 
-perihilar,cellular and tip variants. 
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Biopsy from a patient with focal 
and segmental 
glomerulosclerosis. One 
of the glomeruli shows 
segmental sclerosis, while the 
other appears 
unremarkable. Tubular atrophy is 
also seen. 
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MCD r DMP WITH IgM DEPOITS IN THE MESANGIUM 
 
In addition to the LM and EM findings of MCD or DMP, there are 
deposits of  IgM in the mesangium. 
 
Such patients usually respond very poorly to steroids. 
 
 
CLINICAL FEATURES1,2,6  
 
The typical age group for occurrence of nephrotic syndrome is pre school 
age group.  The patient presents with insidious onset facial puffiness 
more on awakening followed by slowly progressing generalised edema 
which may be associated with oliguria.  There may be a history of 
preceeding respiratory or viral infections which may act as a trigger for 
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nephrotic syndrome.  Some may present with features of severe edema 
like labial or scrotal edema,respiratory compromise due to massive 
ascites.  Occassionally patients may present with diarrhea due to bowel 
wall edema.  Sometimes rarely the patient may present critically ill due to 
peritonitis,bacteremia, pnuemonia or with thrombotic episodes.  Some 
may have symptoms of hypotension like abdominal pain,persistent 
vomiting,dizziness and cold extremities.  These symptoms are due to 
decreased intravascular volume11,21,27. 
  On physical examination, the extent of edema must be assessed.  A 
careful examination must be done to look for any underlying infections 
like Urinary tract infections,pneumonia,peritonitis.  Blood pressure must 
be monitored along with urine output.  Small and large joints must be 
checked for any signs of inflammation or restriction of movements which 
may indicate any collage vascular disorder.  A search for any 
organomegaly must be made which may indicate any underlying disorder 
which can cause secondary nephrotic syndrome. 
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Facial puffiness-one of the initial symptoms of NS 
 
Scrotal edema and ascites in a patient before and after treatment 
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Pitting pedal edema 
 
Patient with massive edema-with both periorbital puffiness and massive ascites 
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Frothy urine in a patient with nephrotic syndrome 
 
LABORATORY EVALUVATION                                
 
INVESTIGATIONS TO CONFIRM THE DIAGNOSIS1,7,12 
Urine analysis of the early morning first samle to look for proteinuria and 
urine spot PCR, blood urea creatinine and serum electrolytes,serum 
triglyceride and cholesterol levels,serum albmin,urine electrolytes and 
FeNa and fractionalurinaryexcretion of potassium to determine the 
intravascular status . 
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INVESTIGATIONS TO RULE OUT INFECTIONS 
Urine culture to rule urinary tract infection,complete blood counts and 
CRP to rule out any infections,Mantoux and chest xray to rule out 
tuberculosis. 
OTHER INVESTIGATIONS WHICH AY BE NEEDED AT TIMES   
USG abdomen to rule out renal anomalies ,Anti nuclear antibody levels 
,renal biopsy if the child is above 10 yrs of age.ASO and C3 levels if 
there is microscopic hematuria in urine microscopy. 
Indications for biopsy in nephrotic syndrome 
-age of onset< 1yr or >10 yrs. 
-gross hematuria,persistent microscopic hematuria or low serum C3. 
-sustained hypertension. 
-renal failure not attributable to hypovolemia. 
-after initial treatment- 
+Proteinuria persisting after 8 weeks of full dose steroid therapy(labeled 
as SRNS) 
+Before starting cyclosporine or tacrolimus. 
+After 2 yrs of therapy with calcineurin inhibitors to check for toxicity. 
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MANAGEMENT 
 
SYPMTOMATIC AND SUPPORTIVE MANAGEMENT1,2,7,8,12 
Any child with massive edema,fever,unstable vital signs,urine outout<0.5 
ml.kg/hr and severe hemoconcentration as suggested by a hematocrit 
more than 48% must be hospitalized. Fluid intake and output, blood 
pressure and daily weight charts must be maintained. 
 + Dietary management 
The child should be placed on “no added” salt regimen i.e 1 to1.5 gms of 
salt per day.  Fluid restriction will be needed. Patients with severe edema 
-insensible water loss of previous day,moderate edema-insensible water 
loss with previous day urine output,mild edema-mild or no fluid 
restricton.  
 Daily recommended allowences of protein are allowed of which 2/3 rd 
must be first class proteins like egg albumin. 
 +Diuretics 
Diuretics are useful in children with moderate to severe edema with 
oliguria.  Intravascular volume status must be assessed with FeNa and 
fractional ppotassium excretion in urine prior to the use of diuretics in 
order to prevent the aggrevation of intravascular depletion which may 
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cause episodes of thrombosis and acute tubular necrosis.  Furosimide is 
the most commonly used diuretic in a dose of 1-2 mg/kg/day either orally 
or intravenously.  Other diuretics like thiazide diuretics,spirinalactone, 
metalazone etc may also be used.  Metalazone is especially useful in 
refractory edema,usually in refractory nephrotic syndromes.  Diuretics 
like metalazone are used half hour prior to the administration of 
furosimide for maximal effect.  Serum levels of potassium must be 
monitored while using diuretics due to their propensity to cause 
hypokalemia.  In paients with intravascular volume contracted states, 
injection human albumin in doses of 1 gm/kg/day over 4hrs may be used 
to improve intravascular status and mobilize the edema.  Fresh frozen 
plasma in doses of 10 ml/kg/day over 4hrs may also be used in case of 
non availability of human albumin.  Human albumin/Fresh frozen plasma 
may also be used is patients with severe edema causing respiratory 
compromise along with diuretics like  furosimide to decrease edema in 
better way. 
+control of any infections like urinary tract infections ,pneumonia 
,peritonitis etc before the start of steroids. 
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+Specific therapy1,7,8 
The main aim of therapy is to induce and maintain remission in active 
nephrotic syndrome while minimizing the side effects due to drugs most 
of which are immunesuppresants. 
-Steroids-these are the mainstay of therapy in newly diagnosed cases of 
nephrotic syndrome. APN regimen for steroids is the one used in ICH and 
HC.  It consists of 2mg/kg/day dose of prednisolone given daily for  6 
weeks followed by 1.5 mg/kg/day every other day for another 6 weeks 
followed by tapering of steroids over 2 weeks.  In patients with infrequent 
relapse, 2 mg/kg/day prednisolone is given daily till remission is achieved 
and then it is followed by 1.5 mg/kg/day every other day for a period of  
4 weeks.  In patients with frequent relapse or steroid dependent nephrotic 
syndrome, a low dose steroid is given at a dose of 0.25-0.75 mg/kg/day 
every other day for a period of  6-18months.  If  the patient needs more 
doses of steroids or develops side effects due to steroids, then alternate 
durgs are introduced. 
-Other immunomodulators- 
Steroid dependent nephrotic syndrome or frequent relapse9,10,13 
In ICH and HC pulse dose of cyclophospamide is used in dose of 500 
mg/m2 given once a month for a duration of 6 months.  Other drugs that 
are used in SDNS/FRNS are levamisole, oral cyclophospamide and 
mycophenolate mofetil in refractory cases. 
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Steroid resistant nephrotic syndrome15,16,17,19 
In our hospital a trial of high dose steroids in the form of pulse methyl 
prednisolone is given in Mendosa Regimen17.  This is followed by use of 
drugs like Tacrolimus ,cyclosporine, a combination of tacrolimus and 
mycophenolate mofetil19 etc if the patient is not responding to Mendosa 
regimen.  If  the patient is still not in remission ,then antiproteinuric 
measures like angiotensin receptor blockrs or AT1 antagonists15 along 
with antihypertensives are used to control proteinuria and hypertension. 
+Vaccination- 
Patients with nephrotic syndrome have unusual susceptibility to 
pneumococcal infection.  Hence IAP recommends the use of  2-4 doses of 
heptavalent pneumococcal conjugate vaccine for children below 2 yrs 
with nephrotic syndrome.  For children between 2-5 yrs , 1 dose of 
heptavalent followed by 1 dose of 23 valent vaccine is recommended 8 
weeks after the first vaccine. 
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SUMMARY AND CONCLUSIONS 
 
Nephrotic syndrome is a common disease in children especially in 
preschool age group.  It is a disease which mainly presents with 
edema,oliguria which are insidious in onset which may or may not be 
associated with hematuria.  There are a multitude of reasons which can 
cause nephrotic syndrome among which idiopathic nephrotic syndrome is 
the commonest form.  In patients with nephrotic syndrome the 
intravascular status can be hypo or hypervolemic despite massive 
edema11,21,27.  The signs of volume depletion can be subtle and not very 
much clinically apparent.  This can be aggrevated by inadvertent use of 
diuretics to mobilize edema which may lead to thrombotic complications 
like renal vein, pulmonary, cereberal thrombosis or acute tubular necrosis 
which all can be life threatening.  Hence it is prudent to measure 
intravascular volume status before instituting the use of diuretics to 
mobilize edema in a patient with nephrotic syndrome. 
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INTRAVASCULAR VOLUME STATUS IN 
FIRST    EPISODE NEPHROTIC SYNDROME 
 
 
INTRODUCTION AND NEED FOR THE STUDY 
 
Nephrotic syndrome is a common disease in children especially in 
preschool age group.  It is a disease which mainly presents with 
edema,oliguria which are insidious in onset which may or may not be 
associated with hematuria.   In patients with nephrotic syndrome the 
intravascular status can be hypovolemic  or hypervolemic despite massive 
edema.  The signs of volume depletion can be subtle and not very much 
clinically apparent.   Volume depletion in patients with nephrotic 
syndrome can present with symptoms like giddiness,abdominal pain 
vomiting etc. which can be very subtle in children or which may not be 
reported at all.  Diuretics are the most common drugs used to treat edema 
in nephrotic syndrome. This state of hypovolemia  can be aggrevated by 
inadvertent use of diuretics to mobilize edema which may lead to 
thrombotic complications like renal vein, pulmonary, cereberal 
thrombosis or acute tubular necrosis which all can be life threatening.  
Hence it is prudent to measure intravascular volume status before 
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instituting the use of diuretics to mobilize edema in a patient with 
nephrotic syndrome. 
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AIM OF THE 
STUDY 
 
 
To study and assess the intravascular volume status in 1st episode 
Nephrotic Syndrome and determine if the patient is hypovolemic or 
hypervolemic to determine the safety of use of diuretics to decrease 
edema in patients with 1 st episode nephrotic syndrome. 
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METHODOLOGY 
 
PLACE OF STUDY 
General pediatric medical wards of  a tertiary care referral government 
hospital-Institute of Child Health and Hospital for Children. 
STUDY DESIGN 
Prospective observational study 
DURATION OF STUDY 
January 2015 to September 2015 
STUDY POPULATION 
Suspected patients with first episode of Nephrotic syndrome. 
INCLUSION CRITERIA 
Children with 
 Proteinuria      >50 mg/kg/day or spot PCR >2 or urine dipstick 2+ 
or more. 
 Serum albumin< 2.5 g/dl. 
 Serum cholesterol>200 mg/dl. 
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EXCLUSION CRITERIA 
 Previous episodes of nephrotic syndrome. 
 Prior use of diuretics for edema during the present episode.  
 
ETHICAL ISSUES 
 Routine blood investigations were sent for the patients from 
general ward for the patients from which the necessary results were 
collected. 
 The necessary urine results were also collected from the routine 
urine tests samples sent from ward for patients under evaluation for 
suspected nephrotic syndrome.   
 Institute ethical committee approval was obtained before the 
commencement of the study. 
 Informed consent from the patient’s paterts was obtained before 
voluntary enrolment into the study. 
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STUDY MANEUVRE 
 
All the general pediatric medical wards were informed about the study 
with a circular explaining the study in short, inclusion criteria for 
enrollment, exclusion criteria and information for informed consent and 
about how to obtain the sample.  Informed consent was obtained from the 
patents before enrollment into the study.  Blood samples were obtained 
with aseptic measures following universal precautions in plain test 
tube(red) provided for the purpose.  First morning urine samples were 
collected in plain urine bottles after washing the perineum with soap.  
Both the urine and blood samples were sent to biochemistry laboratory 
without delay for analysis.  The patients were next taken to Department 
of Cardiology for echocardiogram to measure the IVC collapsibility 
index.  All the testing were done after ensuring that diuretics were not 
given to the patient to decrease edema during this episode of nephrotic 
syndrome. 
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Test tubes used to collect blood samples. 
 
Plain bottles used for urine collection. 
 
 
 47 
 
Dipstick to detect proteinuria 
 
 
 
SAMPLE ANALYSIS 
 
All the samples were sent to biochemistry laboratory without delay. They 
were analyzed by skilled technician in the biochemistry laboratory.  The 
testing was done using the following methods using Erba Manihier EM 
200 auto analyzer- 
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+Serum sodium and potassium-using ion electrode method. 
+serum creatinine-jaffe’s kinetic method. 
+serum proteins- biuret method 
+serum albumin- brome cresol green reagent method measured by 
colorimetric method. 
+urine analysis 
Diluents used-company specified diluents diluted in the ratio of 1:10 
+urine sodium and potassium- ion electrode method. 
+urine creatinine- jaffe’s kinetic method. 
+urine protein-sulphosalycilic acid method measured by colorimetric 
method. 
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Erba Manihier EM 200 auto analyzer used for analysis of blood and urine 
samples. 
 
 
From the above values FeNa and Relative urinary potassium excretion 
will be calculated using the given formulae. 
 FeNa- UNa X PCr X 100/PNa X UCr 
 Fractional urinary excretion of potassium-Uk/Uk+UNa) 
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IVC COLLAPSIBILITY INDEX 
 
IVC collapsibility index was measured using echocardiography in 
Pediatric Cardiology department by trained cardiologist using the 
following given method.  
To image the IVC, the probe was placed in the subxiphoid 4-chamber 
position with the probe marker oriented laterally in order to identify the 
right ventricle and right atrium. Then the probe is progressively aimed 
toward the spinal column, where the convergence of the IVC with the 
right atrium can be seen. The IVC is then followed inferiorly, specifically 
looking for the confluence of the hepatic veins with the IVC . The IVC 
was evaluated in the long-axis plane. For this view, the probe was turned 
from a 4-chamber subxiphoid into a 2-chamber subxiphoid orientation, 
with the probe now aligned in a longitudinal orientation . Though this 
view allows visualization of the IVC throughout the length of the hepatic 
segment, there is a possibility that the true size of the IVC may be 
underestimated in the long axis due to a common error which known as 
the cylinder tangent effect. This effect tends to occurs when the 
ultrasound beam travels via the vessel longitudinally through an off-
centered plane. One of ways to avoid underestimating the size of the IVC 
was to angle the probe slightly laterally and medially until the greatest 
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dimensions of IVC are identified. The diameter of the IVC was then 
measured perpendicular to the long axis of the IVC at end-expiration and 
end-inspiration. The finding of an IVC with large inspiratory collapse 
(high caval index) is suggestive of with low volume states. 
 
 
Echo views of IVC 
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Echo view of IVC in volume contracted state 
 
IVC in hypervolemic state 
 53 
 
 
 
IVC collapsibility index will be calculated using the following formula- 
(IVC dia exp- IVC dia insp)/ IVC dia exp 
 
 
 
From the above values, hypovolemic status will be defined as 
 FENa<1 and 
 Uk/Uk+Una>60% and 
 IVC collapsibility > 50 % 
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The patients not satisfying the above criteria will be classified as having a 
hypervolemic intravascular status. 
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Historical overview 
The term “nephrosis” was coined in the beginning of the 20th century, 
 it was characterized by proliferation and exudation of inflammatory 
cells. Since then, “nephrotic syndrome” was the term used to refer a 
group of similar and related diseases mainly of the kidney. 
The initial records of nephrotic syndrome can be traced back to beginning 
of this era. In the times of old Alexandria, it was thought that urine was 
produced in kidneys. 
  The old saying from Hippocrates was “Bubbles floating upon the 
surface of the urine denote affection of the kidneys, and the disease will 
be long drawn”. 
  In the mid 18th century(1764), Cotungo, first described massive 
edema in a soldier whose urine was later found to be heat coagulable. 
  In the 19th century (1836), proteinuria was noted in some renal 
diseases in patients with the presence of edema by Bright, 
Glomerulonephritis was  known as Bright’s disease for about a 
century. 
  In 1905, Fredrick Muller was the one who first used the term 
“Nephrosis” to distinguish a subset of renal disorders.  Initially, it 
was thought that tubules were the source for the protein leak. 
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Glomeruli were later found to be the cause of protein leak 
finally in the 1940s. 
  Munk, in 1913, found the association of nephrosis and lipoid 
droplets in the urinary sediments in nephrosis patients and coined 
the phrase lipoid nephrosis. 
  To describe patients with proteinuria, edema and hyperlipidemia, 
Clovin and Goldberg started using the terminology “Nephrotic 
Syndrome”. 
  As a treatment of nephrotic syndrome,Synthetic steroid 
hormones (prednisone,  glucocorticoid prodrug) were used since 
1950. Schering and Cepjohn, in 1955, started using prednisolone. 
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STUDIES RELATED TO MY TOPIC 
 
1. Urinary indices in nephrotic syndrome 
 
Published –Indian journal of nephrology,jul-sep 2011  
Authors- M. Sahay et al . Osmania medical college ,Hyderabad  
 
Aim-Children with Nephrotic syndrome with edema may have variable 
intravascular volume status- hypo, hyper or normovolemic status.  
Clinically it is very difficult to determine the volume status.  Hence 
urinary indices may be used to determine the volume status in children 
with nephrotic syndrome. 
Study design-prospective observational study. 
Result and conclusion-measurements of urinary indices are simple 
bedside tools to measure the intravascular status in children with 
nephrotic syndrome.  Children with low urinary sodium excretion with 
high potassium excretion were found to be hypovolemic and needed 
volume expansion before use of diuretics.  Whereas children with FeNa 
>0.2 and frac potassium excretion > 60% were found to be hypervolemic 
and the use of diuretics was found to be safe in them. 
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2. Pathogenesis of edema formation in the nephrotic syndrome 
 
Published –Journal of ped nephrology,March 2001 vol 16 
Authors- JGJ Vande walle ,Docknerwolke et al. 
Result and conclusion- A total 110 children with nephrotic syndrome 
were studied.  Based on the observation from the study, the pathogenesis 
of edema formation were redefined.  The basic defect was identified to be 
faulty excretion by the kidneys.  It was found out that functional 
hypovolemia was found to be associated depending upon the stage in the 
development of the NS, the rate of progression in the development of 
hypoproteinemia, and the absolute levels of plasma oncotic pressure.   
This applied equally to Minimal lesion NS as well as NS with significant 
histological lesions.  Hypovolemia had therapeutic implications.  A quick 
bedside assessment of hypovolemia was made using FeNa and fractional 
excretion of potassium in urine. 
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3. Inferior vena cava indices determine volume load in minimal lesion 
nephrotic syndrome. 
 
Authors-Osman Dönmez, Sevgi Mir, Ruhi Özyürek, Alphan Cura 
, Caner Kabasakal et al. 
Published-Pediatric nephrology, march 2001 vol 16 
Study method- a total of 12 children with minimal lesion NS were 
studied.  They were divided into 3 stages- stage A: edematous; stage B: 
50% decrease in weight gain; stage C: edema free. The ideal weight of all 
patients in stage A was found to be more than the ideal weights . Serum 
total protein, albumin and urine sodium levels were also found to be low 
in these patients.IVC indices to determine the volume load were 
suggestive of hypovolemia in these patients. Plasma rennin activity in 
these patients were found to be significantly different from controls in 
stage A.  PRA and serum aldosterone levels were found to be not 
different in those in stage B from the control group.  However, the 
increase in PRA was found to be significant in stage C. Although there 
was a significant weight decrease in stages B and C, it had no effect on 
IVCI, LAD, and cardiothoracic index. 
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Result and conclusion-  IVCI, IVCCI, and LAD measurements by 
echocardiography (ECHO)were found to be easy and reliable methods to 
assess the intravascular volume load in patients with Minimal lesion NS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 62 
 
4. Caval Sonography in Shock-A Noninvasive Method for Evaluating 
Intravascular Volume in Critically Ill Patients 
  
Authors- Dina Seif, MD, MBA, RDMS⇓, Thomas Mailhot, MD, 
RDMS, Phillips Perera, MD, RDMS and Diku Mandavia, MD et al 
Published- Journal of Ultrasound in Medicine December 1, 2012 vol. 
31no. 12 1885-1890 
Aim- to determine the intravascular volume in critically ill patients with 
shock with the help of bedside ultrasoography. 
Methods-IVC collapsibility indices measured from 2 axis- short axis and 
long axis were used to measure the volume status in critically ill patients 
with shock in the ICU to guide in resuciation. 
Results and conclusion-  Decreased dilatation of the IVC following  a 
fluid challenge was found to be more sensitive than blood pressure in the 
identification of hypovolemia in trauma patients. IVC sonography with 
dilation and decreased collapsibility  rapidly identifies patients with 
congestive heart failure and volume overload. More than a single 
measurement of the IVC, it will be more useful to measure the changes in 
vessel size and collapsibility over time in response to breathing cycle and 
in response to an intervention. 
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Pitfalls- One single long-axis view may not be accurate, hence it is 
recommended to measure the IVC volume in both short and long axes. 
Inferior vena cava indices measurements should be made at or near the 
junction with hepatic veins. Measurements at other places may not reflect 
the actual intravascular volume status. Interpretation of IVC indices is 
improper in conditions that restrict the physiologic variability of the IVC, 
like liver cirrhosis, fibrosis, masses causing external compression of IVC 
and in conditions with elevated intra-abdominal pressure. 
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5. Treatment of Severe Edema in Children with Nephrotic Syndrome 
with Diuretics Alone — A Prospective Study 
 Authors-Gaurav kapur, Rudolph valentine et al. 
Aim- Severe edema in patients with nephrotic syndrome (NS) can be 
associated with volume contraction or volume expansion . Normally, 
severe edema is treated with intravenous albumin and diuretics, which is 
appropriate management for VC patients. But  in VE patients, this can 
result in volume overload. The aim of this study was to evaluate the 
management  of severe edema in NS with diuretics alone. 
Methodology - 30 NS patients having severe edema were enrolled into 
this study in two phases. VC was determined based on fractional 
excretion of sodium (FeNa) <1%. Patients identified with VC received IV 
albumin and furosemide.  VE patients were treated with intravenous 
furosemide and oral spironolactone. Volume contraction was redefined as 
FeNa <0.2 n phase 2 of this study and then this newly defined patients 
received the treatment protocol described above. 
Results and conclusion- In pediatric patients with NS, with FeNa >0.2, 
diuretic therapy alone is safe whereas in patients with FeNa <0.2 , IV 
albumin with diuretics was preferred.  
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6. Pathogenesis of edema formation in the nephrotic syndrome. 
Authors-Palmer BF,Alpen RJ et al. 
Published-kidney international supplement  [1997, 59:S21-7] 
Type- journal article,review. 
Results- The development of edema in the nephrotic syndrome has been 
thought of  as an underfill mechanism. According to this theory, 
albuminuria results in hypoalbuminemia and reduced plasma oncotic 
pressure. As a result of which plasma fluid translocates out of the 
intravascular space and leads to  a decrease in intravascular volume 
status.  In response to this underfilled circulation, compensatory 
mechanisms are then activated that lead the kidney to 
retain salt and water. While an underfill mechanism may be responsible  
for edema formation in a small minority of patients, recent  findings  
suggest that edema formation in most of the nephrotic patients is as a 
result of primary salt retention. Direct measurements of blood and plasma 
volume or measurement of neurohumoral markers that can indirectly 
reflect circulatory volume are mostly consistent with a state of either 
euvolemia or a state of hypervolemia. The intrarenal mechanisms 
responsible for primary sodium retention is not fully elucidated, but may 
involve tubular unresponsiveness to natriuretic effect of atrial natriuretic 
peptide. 
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7. Hypo- and hypervolemic edema in children with steroid sensitive 
nephrotic syndrome 
 
Authors-Mehmet Akif BÜYÜKAVCI , Mahmut ÇİVİLİBAL, Murat 
ELEVLİ , Hatice Nilgün SELÇUK DURU 
 
Published-Turkish journal of medical sciences,jan 2015 
Materials and methods: 32 Steroid sensitive NS patients and 30 healthy 
children were taken in this  study. The intravascular volume status of 
patients were studied by clinical and laboratory parameters, like fractional 
sodium excretion (FENa) and distal sodium/potassium exchange 
(UK/UNa+K ratio). Inferior vena cava collapsibility index (IVCCI), left 
atrial diameter (LAD), aortic diameter (AD), and left ventricular mass 
index (LVMI) were measured using echocardiographic methods.  
 
Results:  While evaluating the volume status of patients, 8 patients (25%) 
were found to be hypovolemic while the rest 24 patients (75%) were 
nonhypovolemic (normovolemic or hypervolemic). LAD was decreased 
in hypovolemic patients.  
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Conclusion: The majority of patients with Steroid Sensitive NS are 
normovolemic or hypervolemic and echocardiography is an easy and 
noninvasive method for the evaluation of volume status in these patients. 
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                RESULTS 
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RESULTS AND ANALYSIS 
 
The results were entered in an excel sheet and were analyzed using open 
epi version 2.3.1 for statistics. 
 A total of 42 patients were included in the study who satisfied the 
inclusion criteria. 
AGE DISTRIBUTION   
The variation in age among the patients was from 1 yr to 10 yrs.  
Among the 42 children, 12 (28.6%) were in the age group between 1 to 3 
years.  There were 24(57.1%) children in the age group between 3 and 6 
years which forms the largest age group in this study.  There were 6 
(14.3%) children of age more than 6 years and less than 10 years. 
          Age distribution of patients in this study 
Age group Frequency Percentage 
1-3 yrs 12 28.6 
3-6 yrs 24 57.1 
6-10 yrs 6 14.3 
Total 42 100 
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SEX DISTRIBUTION OF PATIENTS IN THIS STUDY 
Among the 42 participants, 16 (38.1 %) were found to be females.  26 
(61.9 %) of the total 42 participants were found to be males. 
Gender distribution in this study 
Gender Frequency Percentage 
Male 26 61.9 
Female 16 38.1 
Total 42 100 
 
12 (28.6%)
24 (57.1%)
6 (14.3%)
0
5
10
15
20
25
30
1 - 3 years >3 - 6 years > 6 years
Age distribution in the study population 
(n=42) 
Series 1
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Distribution of the patients in this study according to religion 
6(14.2%) of the patients in my study were Christians ,3 (7 %) were 
Muslims and the rest 33(79%)were from Hinduism religion. 
 
 
 
 
26
(61.9%)
16
(38.1%)
Gender distribution across the study 
participants (n=42)
Males
Females
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Religion Frequency Percentage 
Hinduism 33 79 
Islam 3 7 
Christianity 6 14 
Total 42 100 
 
 
 
There is no statistically significant association of various religious 
cultures with incidence of nephrotic syndrome or its intravascular volume 
status. 
 
hinduism
79%
christianity
14%
islam
7%
religious distribution of patients in this 
study
 73 
 
 
For all the 42 patients, blood and urine samples were sent to test for  
-serum electrolytes 
-serum creatinine 
-urine creatinine and 
-urine electrolytes 
The results were collected and FeNa was calculated for each patient using 
the given formula. 
FeNa- UNa X PCr X 100 
PNa X UCr 
 
A cutoff  of FeNa as <1 or > 1 was taken. 
20(47.6%) patients were found to have a FeNa of less than 1.  22(52.4%) 
out of the 42 patients were found to have a value of FeNa more than 1. 
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            Percentage distribution of FeNa in this study 
FeNa Frequency Percentage 
<1 20 47.6 
>1 22 52.4 
Total 42 100 
    
 
     
      
 
 
FeNa>1
52%
FeNa<1
48%
Percentage distribution of FeNa
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The first morning samples were also analyzed for urine electrolytes.  
From urine electrolytes, Fractional excretion of potassium was calculated 
from the below given formula- 
Fractional urinary potassium excretion- Uk/Uk+Una 
A cutoff of 60 % of fractional urinary excretion of potassium was taken 
for classification. 
16(38.1%) of the 42 patients were found to have a fractional 
urinary excretion of potassium of more than 60 % with a 95 % confidence 
intervals lying between 25 and 53 percentage points.  26 (61.9%) of the 
42patients in this study had a fractional urinary excretion of potassium of 
less than 60 % with 95% confidence  interval lying between 46 and 75 
percentage points . 
 
Distribution of fractional urinary excretion of potassium in this study 
fractional urinary 
excretion of potassium 
Frequency Percentage 
>60 % 16 38.1 
<60 % 26 61.9 
Total 42 100 
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All the 42 patients in the study were taken for echocardiogram in the 
following day to Dept. of Pediatric Cardiology.  IVC collapsibility was 
fractional urinary 
excretion of 
potassium>60%
38%fractional urinary 
excretion of 
potassium<60%
62%
fractional urinary excretion of potassium 
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measured in the subxiphoid views in both the long axis and short axis 
views.  The results were averaged to arrive at a single value of IVCCI 
using the formula- 
IVCCI-(IVC dia exp- IVC dia insp)/IVC dia exp 
 A cutoff of 50 % was taken.  A total of 16(38.1% ) out off 42 patients 
were found to a have an IVCCI < 50 % with a 95 % confidence intervals 
lying between 25 and 53 percentage points.  26(61.9 %) of the total 
patients were found to have an IVCCI > 50 %  with 95% confidence  
interval lying between 46 and 75 percentage points . 
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Frequency of IVCCI in patients in this study 
IVC collapsibility 
index 
Frequency Percentage 
>50 % 16 38.1 
<50 % 26 61.9 
Total 42 100 
 
IVCCI<50%
62%
IVCCI>50 %
38%
IVCCI
<50 >50
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From the above values, hypovolemia was defined as having 
 FENa<1 and 
 Uk/Uk+Una>60% and 
 IVC collapsibility > 50 % 
In this study 16 (38.1%) patients had hypovolemia satisfying the above 
criteria% with a 95 % confidence interval lying between 25 – 53.2 
percentage points.  22(52.4%) patients had FeNa >1 and fractional 
urinary potassium excretion <60 % and IVCCI < 50 % with a 95 % 
confidence interval lying between 37 – 67 percentage points.  Hence 
these patients were classified as hypervolemic.  4(9.5%) patients had a 
FeNa <1 but fractional urinary potassium excretion <60 % and IVCCI < 
50 %% with a 95 % confidence interval lying between 3 – 21 percentage 
points. Since these patients did not satisfy the criteria for hypovolemia 
fully, there were classified as having hypervolemic or normovolemic 
intravascular volume status.  Hence a total of 16(38.1%) patients were 
classified as having hypovolemia whereas the rest of the 26(61.9 %) were 
classified as having hypervolemia or normovolemia(not having 
hypovolemia)with a 95% confidence interval lying between 37.4 to 
67percentage points. 
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Volume status of the patients with 1st episode nephrotic syndrome in this study 
Volume status Frequency Percentage 95 % 
confidence 
interval 
hypovolemic 
(FeNa<1 and 
Urine pot >60% 
and IVC >50) 
16 38.1 [25.0 – 53.2] 
hypervolemic 
(FeNa<1 and 
Urinepot >60% 
and IVC >50) 
andnot 
satisfying 
criteria for 
hypovolemia 
26 61.9 [37.4 – 67.1] 
Total 42 100  
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hypovolemic
38%
hypervolemic
62%
Intravascular volume status of patients 
with 1st episode NS in this study
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DISCUSSION 
The objective of this study was to measure the intravascular volume 
status of the patients presenting with first episode of nephrotic syndrome.  
Clinically intravascular status is very difficult to monitor because it is 
associated with many nonspecific signs and symptoms like giddiness, 
abdominal pain, diarrhea, hypertension etc. which can be very difficult to 
detect in children. Since diuretics are a major class of drugs used to treat 
edema in nephrotic syndrome, it was very vital to measure the 
intravascular volume status in patients for the treatment of edema. 
 In this study a total of 42 patients with first episode of nephrotic 
syndrome who were satisfying the inclusion criteria were included.  
Among the 42 patients , FeNa was found to be <1 in 20 patients denoting 
hypovolemia whereas it was >1 in 22 patients denoting hypervolemia.  
Fractional excretion of potassium was found to be >60 % in 16 patients 
making them hypovolemic whereas it was found to be less than 60 % in 
26 patients making them hypervolemic. IVC CI was found out to be >50 
% in 16 patients making them hypovolemic and in 26 patients it was less 
than 50 % making them hypervolemic. 
 A combination of FeNa < 1 ,fractional excretion >60% and IVCCI 
>50 % was taken as having a hypovolemic intravascular status.  16 
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patients in this study werefound satisfying the above criteria and were 
classified as having an HYPOVOLEMIC INTRAVASCULAR STATUS. 
The patients classified as having hypovolemic intravascular status didn’t 
show any different symptoms or signs than the other subset of patients.  
 4 patients had a FeNa < 1 but fractional excretion of potassium <60 
% and an IVCCI <50 %.  Since these patients did not satisfy the criteria 
for hypovolemia they were classified as hypervolemia or normovolemia 
(not hypovolemia). 
 22 patients in this study had a FeNa > 1 and fractional excretion of 
potassium <60 % and an IVCCI <50 %.  These patients were classified as 
having hypervolemic intravascular status. 
 Hence in this study it was found out that 16 patients out of 42 (38.1 
%) had a HYPOVOLEMIC INTRAVASCULAR STATUS and 26 
patients out of 42 (61.9%) had an INTRAVASCULAR STATUS 
WHICH WAS NOT HYPOVOLEMIC (HYPERVOLEMIC OR 
NORMOVOLEMIC).  Since the patients with hypovolemia presented 
with almost the same symptoms as the ones with hypervolemia and 
diuretics are the drugs used to treat edema as first line, intravascular 
volume status must be assessed using laboratory parameters before the 
institution of diuretics to treat edema to prevent aggravation of a 
decreased intravascular volume status. 
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COMPARISON OF MY STUDY RESULTS WITH THE 
ONES DONE EARLIER 
In a study published by Sahay et al in sep 2001 had concluded some 
patients with nephrotic syndrome are hypovolemic and urinary indices 
are very useful in the evaluation of intravascular volume status in 
nephrotic syndrome. 
In a study published in March 2001 Osman domnez et al showed the 
usefulness of echocardiogram in measuring IVCCI,LAD in measuring the 
intravascular volume status in nephrotic syndrome. 
In a recent study published n Turkish journal of medicine in Jan 2015 
which was also done using FeNa, Fractional urine potassium and 
echocardiography, 25 % of the patients were found to be 
hypovolemic(FeNa <1,frac urine potassium excretion>60 % and 
ivcci>50,increased LAD) whereas the rest 75 % were found to be 
hypervolemic or normovolemic (FeNa >1,frac urine potassium 
excretion<60 % and ivcci<50,decreased LAD ),the results of which are 
almost similar to my study. 
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LIMITATIONS IN MY STUDY 
-There were some delays in transport of samples from 7 general pediatric 
wards to the biochemistry laboratory during busy admission days  . 
-  In many patients the urine and sample were collected on the day of 
admission whereas echo was done in the following day due to restricted 
timings for echo.But it was made sure that diuretics were not used before 
performing the echo. 
-the sample size of my study is only 42 in comparison to some previous 
studies which have done for a larger study group. 
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CONCLUSION AND RECOMMENDATIONS 
The objective of this study was to determine the intravascular volume 
status in first episode of nephrotic syndrome.  This was important because 
diuretics are the first line drugs used to treat edema in patients with 
nephrotic syndrome and if used in patients with hypovolemia , may 
precipitate further volume depletion which can lead to dangerous 
complications like renal vein, pulmonary vein, cerebral vessel thrombosis 
and acute tubular necrosis in the kidney. In this study it was noted that 
38% patients were hypovolemic which is a significant percentage.  
Hypovolemia in nephrotic syndrome can be clinically silent but can be 
detected by simple tests like FeNa ,fractional urinary potassium and 
echocardiography to measure IVCCI which are commonly available in 
many centers and are relatively inexpensive. 
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ABBREVATIONS 
NS - Nephrotic syndrome 
SRNS - Steroid Resistant Nephrotic Syndrome 
SDNS-Steroid dependent nephrotic syndrome 
MCD - Minimal Change Disease 
FSGS - Focal Segmental Glomerular Sclerosis 
MPGN - Membrano Proliferative Glomerulo Nephritis 
DMP - Diffuse Mesangial Proliferation 
MN - Membranous Nephropathy 
GBM - Glomerular Basement Membrane 
GFR - Glomerular Filtration Rate 
LM - Light Microscopy 
EM - Electron Microscopy 
IF - Immuno Fluorescence 
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INFORMED CONSENT FORM 
 
Study place: INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR 
CHILDREN 
Title of the study: INTRAVASCULAR VOLUME STATUS IN 1ST 
EPISODE NEPHROTIC SYNDROME 
 
Name of the investigator  :  V.P.KRISHNAN     
Name of the Participant:   Age:    Sex: 
Hospital number:   Blood sample no: 
    
1. I have read and understood this consent form and the information 
provided to me regarding the participation in the study.  
2. I have had the consent document explained to me.  
3. I have been explained about the nature of the study.  
4. I have been explained about my rights and responsibilities by the 
investigator.  
5. I have informed the investigator of all the treatments I am taking or 
have taken in the past including any native (alternative) treatment.  
6. I have been advised about the risks associated with my participation in 
this study.* 
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7. I agree to cooperate with the investigator and I will inform him/her 
immediately if I suffer unusual symptoms. * 
8. I have not participated in any research study in the past. 
10. I am aware of the fact that I can opt out of the study at any time 
without having to give any reason and this will not affect my future 
treatment in this hospital. * 
11. I am also aware that the investigator may terminate my participation 
in the study at any time, for any reason, without my consent. * 
12. I hereby give permission to the investigators to release the 
information obtained from me as result of participation in this study to the 
sponsors, regulatory authorities, Govt. agencies, and IEC. I understand 
that they are publicly presented.  
13. I have understand that  my  identity will be kept confidential if my 
data are publicly presented  
14. I have had my questions answered to my satisfaction.  
15. I have decided to be in the research study.  
I am aware that if I have any question during this study, I should contact 
the investigator. By signing this consent form I attest that the information 
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given in this document has been clearly explained to me and understood 
by me, I will be given a copy of this consent document.  
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INFORMATION SHEET 
 
Place of study: INSTITUTE OF CHILD HEALTH AND HOSPITAL 
FOR CHILDREN 
Name of Investigator :  V.P.KRISHNAN 
Name of Participant    Age:   Sex:  
Hospital No:       
Study title: INTRAVASCULAR VOLUME STATUS IN 1ST 
EPISODE NEPHROTIC SYNDROME 
• We are conducting a study of assessing  intravascular volume status in 
1st episode nephrotic syndrome. We request you to participate in the study 
• The purpose of this study is to determine the intravascular volume status 
in children with nephrotic syndrome 1st episode and determine the safety 
of use of diuretics to decrease edema. . 
•This will be done by testing FeNa and fractional potassium excretion in 
urine and assessment of IVC collapsibility index by Echocardiogram. 
 • The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will be 
shared. 
• Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not 
result in any loss of benefits to which you are otherwise entitled. 
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• The results of the special study may be intimated to you at the end of 
the study period or during the study if anything is found abnormal which 
may aid in the management or treatment. 
 
 
Signature of investigator                                                                                 
Signature of  
                    
Parent/Gaurdian 
Date: 
                       
 
 
Name and signature / thumb impression of the participant 
/parents/guardian  
Name _________________________ Signature_________________ 
Date________________  
 
Name and Signature of impartial witness:  
Name _________________________ Signature_________________ 
Date________________ 
 
Name and Signature of the investigator or his representative obtaining 
consent:  
Name _________________________ Signature_________________ 
Date______________ 
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DATA COLLECTION FORM 
 
1. Name: 
2. Age: 
3. Gender: 
4. Parent’s name: 
5. Address: 
 
        
6. Phone number: 
7. History :  
 
 
     8. Examination: 
 
  
   
 
9.Lab parameters: 
 FENa 
 Uk/Uk+Una 
 Serum osmolarity 
 IVC collapsibility Index
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S.No Name Age  gender  Lab parameters 
      FENa UK/UK+Una(%) IVC Collapsability Index(%) 
1 prajitha 4  f  0.77 66 60 
2 praveen 3.5  m  2.1 54 42 
3 prem 5  m  1.7 56 40 
4 hamsa 6  f  3.1 40 43 
5 gopi 4.5  m  2.2 38 45 
6 monish 2  m  0.71 68 59 
7 hansika 3  f  1.9 47 40 
8 keerthi 2.5  f  4.1 30 34 
9 karthi 5  m  0.69 72 78 
10 sai dasin 6  m  3.45 42 22 
11 akash 5  m  0.53 70 69 
12 lavanya 5  f  2.6 52 43 
13 tirumalai 4.5  m  0.6 75 70 
14 rakesh 7  m  0.65 64 68 
15 jansi 6  f  1.6 57 40 
16 rani 1.5  f  0.8 65 71 
17 deepika 7.5  f  2.46 48 32 
18 kailash 8  m  2.7 40 34 
19 sai laxmi 2  f  0.7 72 62 
20 arasi 2  f  0.5 77 80 
21 ragavi 3  f  3.8 40 38 
22 raj 4  m  0.7 62 55 
23 ahmed 8  m  1.7 40 40 
24 george 4  m  0.66 45 48 
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25 eben 1.5  m  1.84 36 40 
26 mohamad 2  m  2 50 42 
27 swetha 4  f  0.81 56 48 
28 rajesh 5  m  1.8 52 45 
29 krishna 5  m  0.64 62 58 
30 karim 4  m  2.2 55 44 
31 ram 4  m  0.9 62 58 
32 maya 3  f  1.9 40 40 
33 james 2  m  0.84 47 45 
34 lalit 6  m  0.34 82 78 
35 jose 3  m  1.3 37 40 
36 keerthana 6  f  0.8 40 45 
37 madhu 6  f  0.59 79 65 
38 joseph 5  m  2.8 41 34 
39 priya 5  f  0.25 88 81 
40 arun 4  m  1.9 44 42 
41 amarnath 8  m  0.24 80 73 
42 thomas 7  m  1.3 52 46 
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